Willingness to Accept Reimbursement for Visits to an HIV Clinic for Tuberculosis Preventive Therapy

Overview

Journal Int J Tuberc Lung Dis

Specialty Pulmonary Medicine

Date 2020 Jul 29

PMID 32718409

Citations 5

Authors

J L Kadota

A Katamba

A Musinguzi

F Welishe

J Nabunje

J L Ssemata

C A Berger

M R Kamya

J Namusobya

F C Semitala

A Cattamanchi

D W Dowdy

Affiliations

Soon will be listed here.

Citing Articles

Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.

Semitala F, Kadota J, Musinguzi A, Welishe F, Nakitende A, Akello L PLoS Med. 2024; 21(2):e1004356.

PMID: 38377166 PMC: 10914279. DOI: 10.1371/journal.pmed.1004356.

Efficacy and Safety of Different Drug Regimens for Tuberculosis Preventive Treatment: A Systematic Review and Meta-Analysis.

Shah R, Khakhkhar T, Modi B Cureus. 2023; 15(4):e38182.

PMID: 37252497 PMC: 10224701. DOI: 10.7759/cureus.38182.

Integrating interferon-gamma release assay testing into provision of tuberculosis preventive therapy is feasible in a tuberculosis high burden resource-limited setting: A mixed methods study.

Muchuro S, Makabayi-Mugabe R, Musaazi J, Mayito J, Zawedde-Muyanja S, Nakawooya M PLOS Glob Public Health. 2023; 2(7):e0000197.

PMID: 36962307 PMC: 10022101. DOI: 10.1371/journal.pgph.0000197.

Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.

Semitala F, Kadota J, Musinguzi A, Nabunje J, Welishe F, Nakitende A PLoS Med. 2021; 18(12):e1003875.

PMID: 34914696 PMC: 8726462. DOI: 10.1371/journal.pmed.1003875.

Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives.

Semitala F, Musinguzi A, Ssemata J, Welishe F, Nabunje J, Kadota J Implement Sci Commun. 2021; 2(1):71.

PMID: 34193311 PMC: 8247167. DOI: 10.1186/s43058-021-00173-2.

References

Sibeudu F, Uzochukwu B, Onwujekwe O . Investigating socio-economic inequity in access to and expenditures on routine immunization services in Anambra state. BMC Res Notes. 2017; 10(1):78. PMC: 5286773. DOI: 10.1186/s13104-017-2407-1. View

Munro S, Lewin S, Smith H, Engel M, Fretheim A, Volmink J . Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007; 4(7):e238. PMC: 1925126. DOI: 10.1371/journal.pmed.0040238. View

Fisher E, Lazarus R, Asgary R . Attitudes and Perceptions Towards Access and Use of the Formal Healthcare Sector in Northern Malawi. J Health Care Poor Underserved. 2017; 28(3):1104-1115. DOI: 10.1353/hpu.2017.0100. View

Belknap R, Holland D, Feng P, Millet J, Cayla J, Martinson N . Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial. Ann Intern Med. 2017; 167(10):689-697. PMC: 5766341. DOI: 10.7326/M17-1150. View

Munseri P, Talbot E, Mtei L, von Reyn C . Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania. Int J Tuberc Lung Dis. 2008; 12(9):1037-41. View

Geleto A, Chojenta C, Musa A, Loxton D . Barriers to access and utilization of emergency obstetric care at health facilities in sub-Saharan Africa: a systematic review of literature. Syst Rev. 2018; 7(1):183. PMC: 6234634. DOI: 10.1186/s13643-018-0842-2. View

Hardon A, Akurut D, Comoro C, Ekezie C, Irunde H, Gerrits T . Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007; 19(5):658-65. DOI: 10.1080/09540120701244943. View

Deluca A, Frick M, Lessem E, Kanouse J, Wegener D, Mingote L . Activism on rifapentine pricing: removing cost barriers to improve the uptake of tuberculosis research innovations. Public Health Action. 2015; 4(4):238-42. PMC: 4533504. DOI: 10.5588/pha.14.0089. View

Pathmanathan I, Pevzner E, Cavanaugh J, Nelson L . Addressing tuberculosis in differentiated care provision for people living with HIV. Bull World Health Organ. 2017; 95(1):3. PMC: 5180337. DOI: 10.2471/BLT.16.187021. View

10.

Levine A, Presser D, Rosborough S, Ghebreyesus T, Davis M . Understanding barriers to emergency care in low-income countries: view from the front line. Prehosp Disaster Med. 2007; 22(5):467-70. DOI: 10.1017/s1049023x00005240. View

11.

Martinson N, Barnes G, Moulton L, Msandiwa R, Hausler H, Ram M . New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med. 2011; 365(1):11-20. PMC: 3407678. DOI: 10.1056/NEJMoa1005136. View

12.

Sterling T, Villarino M, Borisov A, Shang N, Gordin F, Bliven-Sizemore E . Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011; 365(23):2155-66. DOI: 10.1056/NEJMoa1104875. View